MDWD News and Press, MediWound Ltd.

2026-03-05 16:56:55 ET More on MediWound MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial information for MediWound Read the full article on Seek...

2026-03-05 16:55:56 ET MediWound Ltd. (MDWD) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST Company Participants Ofer Gonen - Chief Executive Officer Hani Luxenburg - Chief Financial Officer Barry Wolfenson - Executive Vice President of Strategy & Corporate De...

MediWound Files Annual Report on Form 20-F YAVNE, Israel, March 5 , 202 6 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, t oday announced that it has filed its annual report on Form 20-F for the fiscal ...

2026-03-05 11:27:47 ET Image source: The Motley Fool. Thursday, Mar. 5, 2026, at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-03-05 07:06:25 ET More on MediWound Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial information for MediWound Read the full article on Seeking Alpha For further details see: MediWound GAAP EPS...

EscharEx ® Phase III VALUE trial advancing as planned Expanded NexoBrid ® manufacturing facility operational ; regulatory approvals expected in 2026 $17 million revenue in 2025 ; $54 million in cash at year-end; 2026–2028 revenue guidance reaffirmed ...

Transportadora de Gas del Sur SA TGS (TGS) is expected to report $0.51 for Q4 2025 John Wiley & Sons Inc. (WLY) is expected to report $0.86 for Q3 2026 Foghorn Therapeutics Inc. (FHTX) is expected to report $-0.28 for Q4 2025 Costco Wholesale Corporation (COST) is expected to repo...

2026-03-04 10:34:00 ET More on MediWound Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Financial information for MediWound Read the full article on Seeking Alpha For further details see: MediWound Q4 2025 ...

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast Scheduled for Thursday, March 5 th at 8:30 a.m. Eastern Time YAVNE, Israel, February 19, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeuti...

MediWound to Present at Upcoming Investor Conferences YAVNE, Israel, February 17 , 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that its management team will present ...